You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 藥明生物(2269.HK)低開約3% 擬折價約7%配售1.18億股 籌集132億港元
格隆匯 02-03 09:25
格隆匯2月3日丨藥明生物(2269.HK)低開約3%,報116.8港元,成交2.33億港元,總市值4778億港元。藥明生物今早在港交所公吿稱,擬在配售中以每股112港元發行1.18億股股票,將籌集132億港元。配股價較昨日收盤價120.4港元折價約7%。公司擬將一級配售所得款項淨額約40%將用於併購原液/製劑(DS/DP)生產的額外設施以配合迅速增長的研發管線;約40%將用於為多個技術平台(包括微生物及哺乳動物細胞平台)建設更多大型生產設施;約10%將用於mRNA(信使核糖核酸)相關技術投資以進一步賦能其全球客户;及約10%將用作集團的一般營運用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account